Sponsor
The Precision Clot: Global Hemostatic Agents to Reach US$ 4.5 Billion by 2031
In the high-stakes environment of the operating room, controlling blood loss is the primary determinant of patient recovery speed. Valued at US$ 2.6 Billion in 2022, the Global Hemostatic Agents Market is projected to grow to US$ 4.5 Billion by 2031, expanding at a CAGR of 6.2%. As of February 2026, the industry is witnessing a "Biological Pivot." While mechanical agents (like sponges) remain...
0 Commentarii 0 Distribuiri 426 Views 0 previzualizare
Sponsor
Sponsor
Sponsor